during cellular turnover within the renal MPS [3] [4] [5] [6] . Recent characterizations of the renal MPS suggest that rDCs, phenotyped as Gr1 -, may derive from 'noninflammatory' Csf1r + Gr1 -blood monocytes [7, 8] ; however, speculation remains that rDCs at steady state might also convert or mature from 'inflammatory' Csf1r + Gr1 + blood monocytes, particularly following resolution of renal inflammation [4] . Intriguingly, studies utilizing Csf1r-EGFP mice have shown that the renal MPS begins to form in the renal interstitium prior to nephrogenesis [9] , raising the possibility that vestigial niches of intrarenal 'preDCs' might reside within the mature kidney as well. Further research is needed to determine the contribution of these potential intrarenal and circulating sources towards maintenance of the rDC network at steady state.
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Wherever the precursors for the mature rDC network reside anatomically, the major ligand for Csf1r, macrophage colony-stimulating factor, and for Flt3, Flt3 ligand (Flt3L), are emerging as two of its central poietins. Several groups have now demonstrated that granulocyte macrophage colony-stimulating factor-derived DCs, whether propagated from bone marrow cultures ex vivo or detected in vivo, represent inflammatory DCs, not DCs at steady state as originally conceived [3] . Flt3L-derived DCs are phenotypically similar to DCs at steady state [3] , however, and recent studies in nonhuman primates recapitulate murine studies which showed transient increases in all rDC subsets with administration of Flt3L [10] . Similar to the requirement for ligation of Flt3 for homeostatic DC development in peripheral lymphoid tissues [11] , disruption of the Flt3-Flt3L interaction in Renal dendritic cells (rDCs) are major constituents of the mononuclear phagocytic system (MPS) within normal kidneys [1, 2] , but the formation and maintenance of the rDC network is not yet fully understood. rDCs derive from a common bone marrow macrophage and DC precursor, which also gives rise to circulating and patrolling Csf1r + Gr1 + and Csf1r + Gr1 -blood monocytes [3, 4] . Although yet poorly understood for the kidney, studies in other nonlymphoid and lymphoid organs suggest that Csf1r + Gr1 -or Csf1r + Gr1 + blood monocytes or perhaps nonmonocyte 'pre-DCs' may serve as precursors for rDCs e68 vivo may cause a severe deficiency in rDCs [A. Thomson, pers. commun.] . While it is yet unclear whether Flt3L is produced by the renal parenchyma as a trophic factor for rDCs, macrophage colony-stimulating factor is known to be expressed by renal epithelial cells [1] and to maintain conventional and plasmacytoid DCs [12] . In support of this, we have found that tissue-resident mouse rDCs isolated from normal kidneys of adult CX 3 CR1
GFP/+ mice survive and proliferate rather than die when cocultured with mouse renal epithelial cells ex vivo ( fig. 1 ). This conserved ability to proliferate ex vivo suggests that at least a subset of rDCs is not terminally differentiated in vivo.
Experimental evidence is mounting that rDCs help to maintain peripheral tolerance in the kidney at steady state [1] . Exogenous, nonself antigen introduced into normal kidneys is captured by rDCs and presented in draining renal lymph nodes, leading to immune activation and proliferation of antigen-specific CD4 + T lymphocytes [13] . Notwithstanding, normal kidneys must also continually process glomerular ultrafiltrates of blood along the course of nephrons that may contain otherwise harmless endogenous antigens without loss of tolerance to these potential urinary antigens. This was discovered to occur in part through rDC-independent cross-tolerance of CD8 + lymphocytes to these soluble filtrated antigens after bulk transport of the antigens to renal lymph nodes [14] . Any additional role of major histocompatibility complex transfer between rDCs and extrarenal DCs [15] in generating this renal immunity to exogenous antigens versus renal tolerance to endogenous antigens is unclear.
rDCs in Renal Inflammation
Using specific markers to localize rDCs in human biopsy specimens, several new studies have demonstrated renal compartment-specific accumulation of rDC subsets during renal inflammation; however, the pathogenic role of this unique rDC traffic is poorly understood. BDCA1 + conventional and BDCA4 + plasmacytoid rDCs accumulate in the renal interstitium [16] , whereas BDCA2 + plasmacytoid rDCs preferentially accumulate in glomeruli [17] , in patients with active lupus nephritis. Likewise, DC-SIGN + conventional rDCs are not readily detected in diseased glomeruli in other nonproliferative and proliferative glomerular diseases, whereas they occur in abundance, along with BDCA2 + plasmacytoid rDCs, in the renal interstitium [18] . In some cases, tertiary lymphoid aggregates composed of CD21 + follicular rDCs and CD20 + B lymphocytes have been detected in the renal interstitium [19, 20] . Of note, these aggregates have been observed in other nonrenal inflammatory diseases, suggesting a conserved immunologic program executed by DCs, whether resident or recruited [20] . Interestingly, paracrine communications at previously unrecognized renal neuron-rDC interfaces may be an important factor in rDC-mediated inflammation [21] .
While these reports posit a positive correlation suggesting causality between the extent of inflammatory rDC accumulation and renal parenchymal injury, preliminary studies in animal models suggest a more complex role. After sequentially ablating accumulating inflammatory CD11c + rDCs and all other intrarenal and extrarenal CD11c + DC subsets in mice with experimental nephrotoxic nephritis, tubulointerstitial and glomerular injury was observed to be aggravated, not ameliorated [22] . This may be due to a need for inflammatory CD11c + rDCs to induce intrarenal CD4 + T lymphocytes to produce IL-10 that may attenuate other proinflammatory cytokines [22, 23] ; however, given the simultaneous ablation of all other intrarenal and extrarenal CD11c + DC subsets in these studies, several other compensatory immunocytoprotective mechanisms may have been disrupted [24, 25] . In contrast with these potential anti-inflammatory mechanisms is the recent finding that rDCs facilitate the recruitment of detrimental CD4 + T lymphocytes secreting IL-17 following experimental acute urinary obstruction [26] . One possibility that may explain this dichotomy is the dual role of TGF-␤ , which can be produced by DCs and drives the development of regulatory T lymphocytes or Th17 effector T lymphocytes depending on additional cues [27] . Further research is needed to determine the dynamic pathogenic roles of steadystate and inflammatory rDCs during injury to the renal parenchyma, inquiries that will be aided by the development of specific rDC subset ablation systems limited to the kidney [24, 25] .
rDC Surveillance in Acute Kidney Injury
Experimental acute kidney injury models are providing insights into the complexity of immunologic surveillance by rDCs [1] . Recent reports suggest that endogenously expressed ligands for Toll-like receptors contribute to activation of rDCs during renal ischemiareper fusion injury [28] . In contrast, local and systemic inflammation during lipopolysaccharide-induced acute kidney injury may not be sufficient to activate rDCs [29] . Likewise, the acute hypoxia of renal ischemia-reperfusion injury is a presumed stimulus favoring maturation of rDCs via hypoxia-inducible factor-1 ␣ activation [30] , but the contribution of hypoxia as compared to that from other stimuli towards further pro-versus anti-inflammatory activation of rDCs is unclear [31] . For example, hypoxic preconditioning before renal ischemia-reperfusion can also be cytoprotective, marked by the induction of heme oxygenase-1, which may contribute to suppressed maturation of rDCs [32] and their functional role via regulatory T lymphocytes [33] . These paradoxical findings are also exemplified by the recent speculation that TammHorsfall protein, an endogenous renal ligand for Toll-like receptor-4, is protective in renal ischemia-reperfusion injury via rDCs [34] . Together, these studies indicate that much remains to be learned about the integration and timing of various environmental cues in the sentinel priming of tissue-resident rDCs towards immunity and tolerance [35] .
Conclusion
Recent research supports the paradigm that rDCs function at the nexus of innate and adaptive immunity, self-tolerance and tissue homeostasis within the kidney. It is clear that studying the communication between rDCs and other renal parenchymal cell types promises to yield insights into the maintenance and immune modulation of rDCs by homeostatic and environmental cues. While advances have been made in characterizing subsets of tissue-resident and infiltrating rDCs at steady state and during renal injury, further research is needed to determine the surveillance and effector function of these subsets, both within the kidney and after their egress to secondary lymphoid organs. Together, these future inquiries should uncover strategies towards modulating rDCs for therapeutic benefit in various kidney diseases.
